0 NASDAQ Companies - March 28, 2024Praxis Precision Medicines, Inc. Announces Pricing of $200 Million Public OfferingBOSTON, March 28, 2024 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights […]Read More